Variant report
Variant | esv3520513 |
---|---|
Chromosome Location | chr5:29675244-29712272 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:29693881..29696199-chr5:29698670..29700812,2 | K562 | blood: | |
2 | chr5:29367229..29368191-chr5:29697633..29698544,4 | MCF-7 | breast: | |
3 | chr2:119203281..119203921-chr5:29680877..29681838,2 | MCF-7 | breast: | |
4 | chr5:29690755..29693202-chr5:29696667..29699518,2 | MCF-7 | breast: | |
5 | chr5:29367148..29368248-chr5:29697562..29698574,8 | MCF-7 | breast: | |
6 | chr5:29694176..29695942-chr5:29696440..29698391,2 | MCF-7 | breast: | |
7 | chr5:29694176..29695942-chr5:29696440..29698391,2 | MCF-7 | breast: | |
8 | chr5:29693881..29696199-chr5:29698670..29700812,2 | K562 | blood: | |
9 | chr5:29690755..29693202-chr5:29696667..29699518,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370988129 | chr5:29697406-29697407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181256394 | chr5:29697420-29697421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148964277 | chr5:29697436-29697437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544992773 | chr5:29697477-29697478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547497469 | chr5:29697486-29697487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186236120 | chr5:29697498-29697499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536255117 | chr5:29697499-29697500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530313000 | chr5:29697522-29697523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1456630 | chr5:29697536-29697537 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs145680263 | chr5:29697556-29697557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527356235 | chr5:29697564-29697565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190609342 | chr5:29697574-29697575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556427467 | chr5:29697598-29697599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577846382 | chr5:29697602-29697603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545171034 | chr5:29697664-29697665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554254067 | chr5:29697672-29697673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572407291 | chr5:29697679-29697680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543008023 | chr5:29697690-29697691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73756506 | chr5:29697706-29697707 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs531727640 | chr5:29697709-29697710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543774740 | chr5:29697721-29697722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs10461870 | chr5:29697762-29697763 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
23 | rs184153332 | chr5:29697775-29697776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3114529 | chr5:29697809-29697810 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs569590195 | chr5:29697825-29697826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186332007 | chr5:29697913-29697914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542144736 | chr5:29697916-29697917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569349375 | chr5:29697925-29697926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536630134 | chr5:29697939-29697940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190980022 | chr5:29697949-29697950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571572328 | chr5:29697961-29697962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538854719 | chr5:29697985-29697986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10461871 | chr5:29698057-29698058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572594058 | chr5:29698072-29698073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542793943 | chr5:29698078-29698079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10058863 | chr5:29698079-29698080 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs532292008 | chr5:29698124-29698125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576533491 | chr5:29698146-29698147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115590511 | chr5:29698155-29698156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183139465 | chr5:29698163-29698164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532401857 | chr5:29698170-29698171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541316331 | chr5:29698177-29698178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146560957 | chr5:29698206-29698207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75970955 | chr5:29698216-29698217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551326076 | chr5:29698279-29698280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1456626 | chr5:29698317-29698318 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs569386575 | chr5:29698329-29698330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs3114528 | chr5:29698347-29698348 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs73756507 | chr5:29698352-29698353 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs76096288 | chr5:29698363-29698364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29697400-29698400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr5:29705800-29706200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr5:29706000-29707200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr5:29706200-29706600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr5:29706600-29708000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |